Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serena Di Martino

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Pharmacological Research|October 16, 2021
Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatmentTibor Stark, Serena Di Martino, Filippo Drago, et al.
Pharmacology & Therapeutics|September 14, 2022
Are the epigenetic changes predictive of therapeutic efficacy for psychiatric disorders? A translational approach towards novel drug targetsVincenzo Micale, Martina Di Bartolomeo, Serena Di Martino, et al.
Pharmacological Research|August 10, 2024
DNA methylation at cannabinoid type 1 and dopamine D2 receptor genes in saliva samples of psychotic subjects: Is there an effect of Cannabis use?Martina Di Bartolomeo, Andrea Čerňanová, Veronika Petrušová, et al.
Pharmaceutics|May 27, 2023
Fluoxetine Protects Retinal Ischemic Damage in MiceGiovanni Luca Romano, Lucia Gozzo, Oriana Maria Maurel, et al.
International Journal of Molecular Sciences|December 9, 2023
Red Flags in Primary Mitochondrial Diseases: What Should We Recognize?Federica Conti, Serena Di Martino, Filippo Drago, et al.
Pharmacological Reports : PR|May 24, 2024
Prenatal MAM exposure raises kynurenic acid levels in the prefrontal cortex of adult ratsFrancesca Frescura, Tibor Stark, Edoardo Tiziani, et al.
Biomolecules|January 21, 2022
Early Blockade of CB1 Receptors Ameliorates Schizophrenia-like Alterations in the Neurodevelopmental MAM Model of SchizophreniaTibor Stark, Fabio Arturo Iannotti, Serena Di Martino, et al.
European Journal of Pharmacology|February 1, 2025
Retinal pharmacodynamic and pharmacokinetic profile of cannabidiol in an in vivo model of retinal excitotoxicityFederica Conti, Francesca Lazzara, Kyriaki Thermos, et al.
International Journal of Molecular Sciences|February 25, 2023
The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of PsychopathologyMartina Di Bartolomeo, Tibor Stark, Serena Di Martino, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
Safety of Drugs Used in Difficult-to-Treat Epileptic Syndromes: A Disproportionality Analysis Using the Eudravigilance DatabaseArianna Scala, Teresa Angela Trunfio, Chiara Pennisi, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Pharmacological Research|October 16, 2021
Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatmentTibor Stark, Serena Di Martino, Filippo Drago, et al.
Pharmacology & Therapeutics|September 14, 2022
Are the epigenetic changes predictive of therapeutic efficacy for psychiatric disorders? A translational approach towards novel drug targetsVincenzo Micale, Martina Di Bartolomeo, Serena Di Martino, et al.
Pharmacological Research|August 10, 2024
DNA methylation at cannabinoid type 1 and dopamine D2 receptor genes in saliva samples of psychotic subjects: Is there an effect of Cannabis use?Martina Di Bartolomeo, Andrea Čerňanová, Veronika Petrušová, et al.
Pharmaceutics|May 27, 2023
Fluoxetine Protects Retinal Ischemic Damage in MiceGiovanni Luca Romano, Lucia Gozzo, Oriana Maria Maurel, et al.
International Journal of Molecular Sciences|December 9, 2023
Red Flags in Primary Mitochondrial Diseases: What Should We Recognize?Federica Conti, Serena Di Martino, Filippo Drago, et al.
Pharmacological Reports : PR|May 24, 2024
Prenatal MAM exposure raises kynurenic acid levels in the prefrontal cortex of adult ratsFrancesca Frescura, Tibor Stark, Edoardo Tiziani, et al.
Biomolecules|January 21, 2022
Early Blockade of CB1 Receptors Ameliorates Schizophrenia-like Alterations in the Neurodevelopmental MAM Model of SchizophreniaTibor Stark, Fabio Arturo Iannotti, Serena Di Martino, et al.
European Journal of Pharmacology|February 1, 2025
Retinal pharmacodynamic and pharmacokinetic profile of cannabidiol in an in vivo model of retinal excitotoxicityFederica Conti, Francesca Lazzara, Kyriaki Thermos, et al.
International Journal of Molecular Sciences|February 25, 2023
The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of PsychopathologyMartina Di Bartolomeo, Tibor Stark, Serena Di Martino, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
Safety of Drugs Used in Difficult-to-Treat Epileptic Syndromes: A Disproportionality Analysis Using the Eudravigilance DatabaseArianna Scala, Teresa Angela Trunfio, Chiara Pennisi, et al.
Pageof 1